Cencic, Regina

Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol

Cencic, R., Carrier, M., Galicia-Vázquez, G., Bordeleau, M.-E., Sukarieh, R., Bourdeau, A., Brem, B., Teodoro, J. G., Greger, H., Tremblay, M. L., et al. (2009) · PLoS ONE

RNA and protein synthesis mechanismsPI3K/AKT/mTOR signaling in cancer

Cited by 302

c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation

Lin, C.-J., Cencic, R., Mills, J. R., Robert, F., & Pelletier, J. (2008) · Cancer Research

RNA and protein synthesis mechanismsPI3K/AKT/mTOR signaling in cancer

Cited by 180

Protospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage

Cencic, R., Miura, H., Malina, A., Robert, F., Ethier, S., Schmeing, T. M., Dostie, J., & Pelletier, J. (2014) · PLoS ONE

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 117

Synthesis of Rocaglamide Hydroxamates and Related Compounds as Eukaryotic Translation Inhibitors: Synthetic and Biological Studies

Rodrigo, C. M., Cencic, R., Roche, S. P., Pelletier, J., & Porco, J. A. (2012) · Journal of Medicinal Chemistry

RNA and protein synthesis mechanismsPI3K/AKT/mTOR signaling in cancer

Cited by 99

Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors

Chu, J., Zhang, W., Cencic, R., Devine, W. G., Beglov, D., Henkel, T., Brown, L. E., Vajda, S., Porco, J. A., & Pelletier, J. (2019) · Cell Chemical Biology

RNA and protein synthesis mechanismsPI3K/AKT/mTOR signaling in cancer

Cited by 74

Assessing eukaryotic initiation factor 4F subunit essentiality by CRISPR-induced gene ablation in the mouse

Sénéchal, P., Robert, F., Cencic, R., Yanagiya, A., Chu, J., Sonenberg, N., Paquet, M., & Pelletier, J. (2021) · Cellular and Molecular Life Sciences

RNA and protein synthesis mechanismsPI3K/AKT/mTOR signaling in cancer

Cited by 20